The 50-day moving average for CATY moved above the 200-day moving average on November 07, 2023. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Moving Average Convergence Divergence (MACD) for CATY just turned positive on November 29, 2023. Looking at past instances where CATY's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .
CATY moved above its 50-day moving average on November 14, 2023 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CATY crossed bullishly above the 50-day moving average on November 09, 2023. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CATY advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 255 cases where CATY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for CATY moved out of overbought territory on November 06, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 32 similar instances where the indicator moved out of overbought territory. In of the 32 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 65 cases where CATY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on November 29, 2023. You may want to consider selling the stock, shorting the stock, or exploring put options on CATY as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CATY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CATY broke above its upper Bollinger Band on November 02, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CATY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CATY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.008) is normal, around the industry mean (1.010). P/E Ratio (7.236) is within average values for comparable stocks, (17.403). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.349). Dividend Yield (0.037) settles around the average of (0.045) among similar stocks. P/S Ratio (3.265) is also within normal values, averaging (2.568).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
|MFs / NAME||Price $||Chg $||Chg %|
|Delaware Ivy Core Equity Fund Class R6|
|American Funds Growth Fund of Amer F2|
|Loomis Sayles Small Cap Value N|
|Nationwide GQG US Quality Eq A|
|State Street Instl Small-Cap Equity Inv|
A.I.dvisor indicates that over the last year, CATY has been closely correlated with ABCB. These tickers have moved in lockstep 86% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATY jumps, then ABCB could also see price increases.